Results 71 to 80 of about 27,268 (276)

Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia

Case Reports in Gastroenterology
Introduction: Hypophosphatemia occurs commonly in inflammatory bowel disease (IBD) patients and can cause considerable morbidity. The differential diagnoses in IBD include nutritional causes and hypophosphatemia induced by some formulations of ...
Kate Hawke, Anthony Croft, Syndia Lazarus   +2 more
doaj   +1 more source

Primary hyperparathyroidism can generate recurrent pancreatitis and secondary diabetes mellitus – A case report [PDF]

, 2019
Introduction. Acute or recurrent pancreatitis may be a complication of primary hyperparathyroidism and patients with previous episodes of pancreatitis may develop secondary diabetes mellitus. Case report.
Dănciulescu Miulescu, Rucsandra Elena, Guja, Loreta, Mîndrescu, Nicoleta, Văcaru, Georgeta, Ștefănescu, Emil   +4 more
core   +2 more sources

Revisiting the Genetics of Hypophosphatasia

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
Overview of the genetic concepts in hypophosphatasia reviewed in this manuscript. ABSTRACT Hypophosphatasia (HPP) is a rare, inherited monogenic disorder that is typically caused by variants in the tissue‐nonspecific alkaline phosphatase (ALPL) gene.
Priya S. Kishnani, Catherine Rehder, Keiichi Ozono, Jordi Pérez‐López, Guillermo del Angel, William R. Mowrey, Meena Balasubramanian, Wolfgang Högler, Eric T. Rush   +8 more
wiley   +1 more source

Nomogram for predicting early hypophosphatemia in term infants

BMC Pediatrics
Background Physiological processes rely on phosphate, which is an essential component of adenosine triphosphate (ATP). Hypophosphatasia can affect nearly every organ system in the body.
Wan Tao, Shina Zhan, Yingjie Shen, Tianjiao Zhao, Feitian Li, Miao Gao, Tingting Yang, Jinqian Yu   +7 more
doaj   +1 more source

A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan

Bone Reports
Intravenous iron replacement therapy is a common treatment for iron deficiency. Commonly used agents in this treatment include ferric carboxymaltose, ferric derisomaltose, and saccharated ferric oxide (SFO).
Teruhisa Kinoshita, Yuki Kondo, Yuka Sakazaki, Hiroki Imaizumi, Norio Takimoto, Yoichi Ishitsuka   +5 more
doaj   +1 more source

Hypophosphatemia after hemodialysis and its association with some clinical complications in patients with chronic kidney disease

Caspian Journal of Internal Medicine, 2022
Background: Beyond the adverse effects of hyperphosphatemia in patients with chronic kidney disease (CKD(, hypophosphatemia has also been proposed as a common challenge after dialysis.
Mohammadreza Ardalan, Ali Safaei, Audrey Tolouian, Ramin Tolouian, Vahideh Ebrahimzadeh-Attari, Mahsa Jalili   +5 more
doaj  

Impact of hypophosphatemia on outcome of patients in intensive care unit: a retrospective cohort study

BMC Anesthesiology, 2019
Background Hypophosphatemia generally occurs in Intensive Care Units (ICUs), but its impact is often ignored. The aim of this study was to investigate whether hypophosphatemia can be a risk factor for ICU 28-day mortality.
Lichun Wang, Chaoxing Xiao, Lei Chen, Xiaofei Zhang, Qiuye Kou   +4 more
doaj   +1 more source

Prévalence et déterminants de l'hypophosphatémie sévère dans un service de Médecine interne [PDF]

, 2012
L'hypophosphatémie sévère définie comme une phosphatémie plasmatique < 0.32 mmol/l (Norme : 0.8-1-4 mmol/l) est associé à une morbidité et mortalité accrues. Il s'agit d'un trouble électrolytique dont la prévalence a été évaluée entre 0.24-0.42 % dans
Zanetti, B.
core  

Enamel and dentin mineralization in familial hypophosphatemic rickets: a micro-CT study [PDF]

, 2015
Objectives: The aim of the present study was to analyse the mineralization pattern of enamel and dentin in patients affected by X-linked hypophosphatemic rickets (XLHR) using micro-CT (µCT), and to associate enamel and dentin mineralization in primary ...
Costa, F. W. G., Fonteles, C. S. R., Ribeiro, T. R., Soares, E. C. S., Williams, J. R., Jr.   +4 more
core   +1 more source

Nanoliposomal Irinotecan in Combination With 5‐Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum‐Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial

Cancer Medicine, Volume 14, Issue 20, October 2025.
ABSTRACT Purpose To evaluate the efficacy and safety of nanoliposomal irinotecan (nal‐IRI) plus 5‐fluorouracil (5‐FU) and leucovorin (LV) in patients with platinum‐refractory or intolerant head and neck squamous cell carcinoma (HNSCC) and esophageal squamous cell carcinoma (ESCC).
Muh‐Hwa Yang, Shang‐Yin Wu, I‐Wei Ho, Nai‐Jung Chiang, Chin‐Fu Hsaio, Chen‐Yuan Lin, Ming‐Yu Lien, Peter Mu‐Hsin Chang, Jia‐Hong Chen, Ching‐Yun Hsieh, Ruey‐Long Hong, Chao‐Tung Lee, Li‐Tzong Chen, Tsang‐Wu Liu, Chang‐Fang Chiu, Li‐Yuan Bai   +15 more
wiley   +1 more source